CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

DAILY EQUITY REPORT

7tH january 2015

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

INDIAN MARKET

INDIAN FACE

INDICES

CLOSE

PREVIOUS

SENSEX

26987.46

27,842.32

NIFTY

8127.35

8,378.40

INDIAN EQUITY BENCHMARK posted its seventh biggest

single-day fall in history, amid weak global cues, after the

ASIAN MARKET

sharp fall in global crude oil prices raised worries over global

INDICES

CLOSE

PREVIOUS

growth slowdown and the political uncertainty in Greece also

NIKKEI

16,883.19

17,408.71

weighed on market sentiment.

HANG SENG

23,485.41

23,721.32

KOSPI

1,882.45

1,915.75

SECTORIAL INDICES

Further, Jubilant Life Sciences rose 3.40% after the company

said it received final approvals from the US health regulator

INDICES

CLOSE

CHANGE (%)

CNX 100

8,133.90

-2.98

S&P CNX 500

6,656.80

-2.93

CNX MIDCAP

12,325.70

-3.03

62.57% to 1,073 vehicles in December 2014 over December

CNX 200

4,205.65

-2.96

2013.

BANK NIFTY

18,430.75

-3.08

for two generic drugs in the US market.

SML Isuzu rose 4.61% after the company said its sales surged

GLOBAL FACE

TOP GAINERS
SCRIPT

CLOSE

CHANGE (%)

HUL

772.00

1.54

COALINDIA

380.50

0.07

TOP LOSERS

Asian shares slumped as sliding oil prices and political

uncertainty in Greece forced investors out of riskier assets
and into the safety of government bonds, while the euro
wallowed near nine-year lows.

European shares resumed their sell-off after a slump in the

previous session caused by worries over Greece, with energy

SCRIPT

CLOSE

CHANGE (%)

JINDALSTEL

151.40

-7.03

ONGC

331.75

-6.06

SSLT

208.10

-5.32

TATASTEEL

395.40

-5.11

stocks declining as the oil price hit new lows.

US index futures poised for a lower opening at the Wall Street

on Tuesday.

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

MARKET MOVERS UPSIDE

NIFTY SPOT

SCRIPT

CLOSE

HUL

774.70

CHANGE
(%)
1.89

S3

S2

S1

7755

7972

8049

TREND

STRATEGY

BULLISH

BUY ON DIPS
PIVOT POINTS
P
R1

8188

8266

SUPPORT
S1-8075
S2-7995

NIFTY

R2

R3

8405

8621

RESISTANCE
R1-8275
R2-8358

MARKET MOVERS DOWNSIDE

SCRIPT

CLOSE

TCS

2446.60

CHANGE
(%)
[3.69]

ONGC

333.15

[5.66]

ITC

360.25

[2.57]

RELIANCE

836.10

[4.54]

FII & DII ACTIVITY

INSTITUTION

NET BUY
(CR.)

NET SELL
(CR)

FII

3517.53

3336.07

DII

1696.37

2011.01

BANK NIFTY FUTURE

TREND
BULLISH
PIVOT POINTS
S3

17576

NSE TOTALS
INDICES

ADVANCES

DECLINES

NIFTY

48

BANK NIFTY

12

STRATEGY
BUY ON DIPS

S2

S1

R1

18125

18323

18674

18872

BANK NIFTY

SUPPORT
S1-18410
S2-18150

R2

R3

19223

19772

RESISTANCE
R1-18850
R2-19025

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

r

MARKET TALKS

January month at project Rs4,200 per tonne for lumps and

Essel Propack boosts mfg capacity in

Egypt, China

Rs3,060 per tonne for fines, which had cut prices by 3 -5% in line
with falling global prices.9MFY15, the company maintained 10%
growth in its output. Sentimentally positive.

Essel Propack Ltd has expanded manufacturing capabilities in Egypt

and China to cater to FMCG and cosmetic brands in West Asian,
African and Chinese markets. It will cater to the needs of non-oral

care category. The plant is strategically located in the hub of

Honda Cars India increase vehicle

prices

multinational and domestic cosmetic brands.

Honda Cars India has increased vehicle prices in the range of Rs

15,000 to Rs 60,000 following the expiry of the concessional

Maruti Suzuki invites quotations from

vendors for YCA

excise duty benefit. The move is on expected lines and other

makers including Maruti Suzuki to announce price increases in
the coming days.

Maruti Suzuki has invited quotations from vendors for the car project
code named YCA which will be the first product to roll out from the
upcoming Gujarat facility. As per media report, the company has
indicated a timeline of mid 2017 for the first roll-out from the facility.

Jubilant gets USFDA

Mycophenolate Mofetil

nod

for

The company is yet to get the minority shareholder approval for the
Gujarat facility but has started construction work in order to adhere to

Jubilant Life Sciences gets USFDA nod for Mycophenolate

the timeline. Positive for Maruti.

Mofetil (market size US$250mn) & Rizatriptan (market size

US$70mn); positive. Jubilant has got USFDA approvals for two of

NMDC to keep prices of iron ore

unchanged for January

its ANDA, namely Mycophenolate Mofetil and Rizatriptan Tablets.

Mycophenolate Mofetil USP, 250 mg Capsules and 500 mg
Tablets is the generic version of Cellcept (of Roche), an
immunosuppressant which is used to help prevent organ rejection

NMDC decided to keep prices of its iron ore unchanged for the

in transplants.

DISCLAIMER
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through
our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment
advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary
authority over your trading or investment accounts.
All rights reserved.